AI Article Synopsis

  • The study aimed to explore how androgen deprivation therapy (ADT) affects depression and cognitive functions in men with advanced prostate cancer.
  • It involved 144 patients, comparing those on ADT for 12 months to a control group that had undergone surgery; results revealed significant cognitive declines and higher depression scores in the ADT group.
  • Findings suggest that ADT increases depression and impairs cognitive abilities like language and memory, highlighting the need for careful consideration before prescribing ADT to older patients with other health issues.

Article Abstract

Aim: To investigate association of androgen deprivation therapy (ADT) with depression and the effect of depression on cognitive functions in men with locally advanced or metastatic prostate cancer.

Methods: A total of 144 patients were evaluated in a prospective, comparative study. Group1 consisted of 72 patients with locally advanced or metastatic prostate cancer who received complete ADT treatment continuously for 12 months and group2 (control group) consisted of 72 patients who underwent radical prostatectomy without any additional treatment. MoCA (The Montreal Cognitive Assessment) and HAM-D (Hamilton depression rating scale) tests were used to assess the effects of ADT on depression and cognitive functions.

Results: According to post-treatment results of MoCA test, patients had lower mean total scores in both the groups. The deficits were especially prominent in the areas of language ability and short-term memory capacity. In the comparison of two groups according to HAM-D tests, the scores were significantly higher in group1 at baseline-6 month, at baseline-12 month and at 6-12 month follow-up period ( = .003,  < .001,  = .023).There was a relationship between depression and deterioration of language and memory functions at 6th ( < .001,  = .002) and 12th months ( < .001,  = .046). Attention function was deteriorated in these patients at 6th ( < .001) and 12th months ( < .001).

Conclusions: ADT causes increase in depression and the deterioration of cognitive functions. ADT should be given carefully to these older group of patients with concomitant morbidities.

Download full-text PDF

Source
http://dx.doi.org/10.1080/13685538.2019.1586869DOI Listing

Publication Analysis

Top Keywords

locally advanced
12
advanced metastatic
12
metastatic prostate
12
androgen deprivation
8
deprivation therapy
8
prostate cancer
8
comparative study
8
adt depression
8
depression cognitive
8
consisted patients
8

Similar Publications

Manganese-based (Mn-based) layered oxides have emerged as competitive cathode materials for sodium-ion batteries (SIBs), primarily due to their high energy density, cost-effectiveness, and potential for mass production. However, these materials often suffer from irreversible oxygen redox reactions, significant phase transitions, and microcrack formation, which lead to considerable internal stress and degradation of electrochemical performance. This study introduces a high-entropy engineering strategy for P2-type Mn-based layered oxide cathodes (HE-NMCO), wherein a multi-ingredient cocktail effect strengthens the lattice framework by modulating the local environmental chemistry.

View Article and Find Full Text PDF

Quantum entanglement-correlations of particles that are stronger than any classical analog-is the basis for research on the foundations of quantum mechanics and for practical applications such as quantum networks. Traditionally, entanglement is achieved through local interactions or via entanglement swapping, where entanglement at a distance is generated through previously established entanglement and Bell-state measurements. However, the precise requirements enabling the generation of quantum entanglement without traditional local interactions remain less explored.

View Article and Find Full Text PDF

Photocatalytic nitrogen (N2) fixation over semiconductors has always suffered from poor conversion efficiency owing to weak N2 adsorption and the difficulty of N≡N triple bond dissociation. Herein, a Co single-atom catalyst (SAC) model with a C-defect-evoked CoP4 distorted configuration was fabricated using a selective phosphidation strategy, wherein P-doping and C defects co-regulate the local electronic structure of Co sites. Comprehensive experiments and theoretical calculations revealed that the distorted CoP4 configuration caused a strong charge redistribution between the Co atoms and adjacent C atoms, minimizing their electronegativity difference.

View Article and Find Full Text PDF

Metasurface-Based Phosphor-Converted Micro-LED Architecture for Displays─Creating Guided Modes for Enhanced Directionality.

ACS Nano

December 2024

Department of Physics of Information in Matter and Center for Nanophotonics, NWO-I Institute AMOLF, Science Park 104, NL 1098XG Amsterdam, The Netherlands.

Phosphor-converted micro-light emitting diodes (micro-LEDs) are a crucial technology for display applications but face significant challenges in light extraction because of the high refractive index of the blue pump die chip. In this study, we design and experimentally demonstrate a nanophotonic approach that overcomes this issue, achieving up to a 3-fold increase in light extraction efficiency. Our approach involves engineering the local density of optical states (LDOS) to generate quasi-guided modes within the phosphor layer by strategically inserting a thin low-index spacer in combination with a metasurface for mode extraction.

View Article and Find Full Text PDF

Neoantigen-Displaying Protein Nanoparticles as a Therapeutic Cancer Vaccine Against Melanoma.

Adv Healthc Mater

December 2024

Department of Biological Sciences, KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Daejeon, 34141, Republic of Korea.

Although interest in peptide-based cancer vaccines has surged in the era of personalized immunotherapy enabled by the discovery of neoantigens, the effective generation of neoantigen-specific T cell responses has been limited. Here, a Brucella BP26 protein-based nanoparticle displaying the MHC class II-restricted melanoma neoantigen, M30, is reported for use as a therapeutic cancer vaccine. Genetic engineering of 10 tandem repeats of the M30 neoepitope to a BP26 monomer results in the self-assembled, neoantigen-displaying protein nanoparticles (BP26-M30 NPs).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!